Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Childs

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Pharmacotherapy|September 2, 2006
Use of heparin versus lepirudin flushes to prevent withdrawal occlusion of central venous access devicesMcDonald K Horne, Donna Jo McCloskey, Karim Calis, et al.
Journal of Psychosocial Oncology|August 29, 2015
Spiritual Well-Being in Hispanic and Non-Hispanic Survivors of Allogeneic Hematopoietic Stem Cell TransplantationPatricia Prince, Sandra A Mitchell, Leslie Wehrlen, et al.
Frontiers in Immunology|June 25, 2019
Enhanced Bone Marrow Homing of Natural Killer Cells Following mRNA Transfection With Gain-of-Function Variant CXCR4<sup>R334X</sup>Emily Levy, Robert Reger, Filip Segerberg, et al.
Cancer Research|July 20, 2006
Bortezomib and depsipeptide sensitize tumors to tumor necrosis factor-related apoptosis-inducing ligand: a novel method to potentiate natural killer cell tumor cytotoxicityAndreas Lundqvist, Scott I Abrams, David S Schrump, et al.
Obstetrics and Gynecology|November 6, 2007
Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantationPamela Stratton, Maria L Turner, Richard Childs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2012
Toso, a functional IgM receptor, is regulated by IL-2 in T and NK cellsYousuke Murakami, Sriram Narayanan, Su Su, et al.
International Journal of Cancer|March 19, 2013
Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signalingErik Wennerberg, Dhifaf Sarhan, Mattias Carlsten, et al.
Nature Clinical Practice. Oncology|December 2, 2006
Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?Pawel Muranski, Andrea Boni, Claudia Wrzesinski, et al.
The Journal of Infectious Diseases|January 10, 2014
Voriconazole metabolism, toxicity, and the effect of cytochrome P450 2C19 genotypeDimitrios Zonios, Hiroshi Yamazaki, Norie Murayama, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2005
Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survivalEdward Gorak, Nancy Geller, Ramaprasad Srinivasan, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Pharmacotherapy|September 2, 2006
Use of heparin versus lepirudin flushes to prevent withdrawal occlusion of central venous access devicesMcDonald K Horne, Donna Jo McCloskey, Karim Calis, et al.
Journal of Psychosocial Oncology|August 29, 2015
Spiritual Well-Being in Hispanic and Non-Hispanic Survivors of Allogeneic Hematopoietic Stem Cell TransplantationPatricia Prince, Sandra A Mitchell, Leslie Wehrlen, et al.
Frontiers in Immunology|June 25, 2019
Enhanced Bone Marrow Homing of Natural Killer Cells Following mRNA Transfection With Gain-of-Function Variant CXCR4<sup>R334X</sup>Emily Levy, Robert Reger, Filip Segerberg, et al.
Cancer Research|July 20, 2006
Bortezomib and depsipeptide sensitize tumors to tumor necrosis factor-related apoptosis-inducing ligand: a novel method to potentiate natural killer cell tumor cytotoxicityAndreas Lundqvist, Scott I Abrams, David S Schrump, et al.
Obstetrics and Gynecology|November 6, 2007
Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantationPamela Stratton, Maria L Turner, Richard Childs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2012
Toso, a functional IgM receptor, is regulated by IL-2 in T and NK cellsYousuke Murakami, Sriram Narayanan, Su Su, et al.
International Journal of Cancer|March 19, 2013
Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signalingErik Wennerberg, Dhifaf Sarhan, Mattias Carlsten, et al.
Nature Clinical Practice. Oncology|December 2, 2006
Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?Pawel Muranski, Andrea Boni, Claudia Wrzesinski, et al.
The Journal of Infectious Diseases|January 10, 2014
Voriconazole metabolism, toxicity, and the effect of cytochrome P450 2C19 genotypeDimitrios Zonios, Hiroshi Yamazaki, Norie Murayama, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2005
Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survivalEdward Gorak, Nancy Geller, Ramaprasad Srinivasan, et al.
Pageof 9